State of Wisconsin Investment Board
APRE icon

State of Wisconsin Investment Board’s Aprea Therapeutics APRE Stock Holding History

State of Wisconsin Investment Board’s Portfolio APRE Stock Details APRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-500
Closed -$241K – 1985
2020
Q3 		$241K Hold
500
– – ﹤0.01% 1886
2020
Q2 		$388K Hold
500
– – ﹤0.01% 1494
2020
Q1 		$348K Buy
+500
New +$367K ﹤0.01% 1447

Other funds holding APRE

VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
CCM
CAAS Capital Management New York $934M AUM 1.45% 1-Year Est. Return

State of Wisconsin Investment Board's APRE Position: Q4 2020 in Review

State of Wisconsin Investment Board sold out of Aprea Therapeutics (APRE) in Q4 2020, closing a stake of 500 shares — an estimated $241K sold.

State of Wisconsin Investment Board first reported a position in APRE in Q1 2020 and held it in 3 quarters. The position peaked at $388K in Q2 2020. 66 funds tracked by Wall St. Rank hold APRE as of Q4 2020.

  • State of Wisconsin Investment Board reported no remaining Aprea Therapeutics position as of Q4 2020 after selling out during the quarter.
  • State of Wisconsin Investment Board sold 500 Aprea Therapeutics shares in Q4 2020, an estimated $241K.
  • State of Wisconsin Investment Board first reported a position in Aprea Therapeutics in Q1 2020 and held it in 3 quarters.
  • State of Wisconsin Investment Board's Aprea Therapeutics position peaked at $388K in Q2 2020.
  • 66 funds tracked by Wall St. Rank held Aprea Therapeutics as of Q4 2020.

Based on State of Wisconsin Investment Board's 13F filing for Q4 2020, filed 3 Feb 2021.